Trials / Unknown
UnknownNCT05750381
Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- BLIS Technologies Limited · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the elbow and back of forearm in a topical balm format in healthy adults.
Detailed description
This is a randomized double-blind, placebo-controlled pilot study with no crossover for the assessment of any changes to the microbial make-up of the skin (The local skin microbiome), detection of colonisation by the probiotic bacterium (BLIS Q24) on the skin and to evaluate the changes in skin quality parameters following topical application of probiotic in a balm format.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Micrococcus luteus Blis Q24 balm | Balm formulation containing probiotic bacteria Micrococcus luteus Q24 for topical applications. |
| OTHER | Placebo balm | Placebo balm formulation for topical applications. |
Timeline
- Start date
- 2023-01-24
- Primary completion
- 2023-03-10
- Completion
- 2023-04-12
- First posted
- 2023-03-01
- Last updated
- 2023-03-01
Locations
1 site across 1 country: New Zealand
Source: ClinicalTrials.gov record NCT05750381. Inclusion in this directory is not an endorsement.